Differential toxicological response to positively and negatively charged nanoparticles in the rat brain

References

• Altman J, Das GD. 1965. Autoradiographic and histological evidence of postnatal hippocampal neurogenesis in rats. J Comp Neurol 124(3):319–335.
   PubMed Web of Science ®Google Scholar
• Andresen TL, Jensen SS, Jorgensen K. 2005. Advanced strategies in liposomal cancer therapy: problems and prospects of active and tumor specific drug release. Prog Lipid Res 44(1):68–97.
   PubMed Web of Science ®Google Scholar
• Andresen TL, Thompson DH, Kaasgaard T. 2010. Enzyme-triggered nanomedicine: drug release strategies in cancer therapy. Mol Membr Biol 27(7):353–363.
   PubMed Web of Science ®Google Scholar
• Arvizo RR, Miranda OR, Thompson MA, Pabelick CM, Bhattacharya R, Robertson JD, et al. 2010. Effect of nanoparticle surface charge at the plasma membrane and beyond. Nano Lett 10(7):2543–2548.
   PubMed Web of Science ®Google Scholar
• Bessis A, Bechade C, Bernard D, Roumier A. 2007. Microglial control of neuronal death and synaptic properties. Glia 55(3):233–238.
   PubMed Web of Science ®Google Scholar
• Best PJ, White AM, Minai A. 2001. Spatial processing in the brain: the activity of hippocampal place cells. Annu Rev Neurosci 24:459–486.
   PubMed Web of Science ®Google Scholar
• Colvin VL, Kulinowski KM. 2007. Nanoparticles as catalysts for protein fibrillation. Proc Natl Acad Sci USA 104(21):8679–8680.
   PubMedGoogle Scholar
• Daemen T, Hofstede G, Ten Kate MT, Bakker-Woudenberg IA, Scherphof GL. 1995. Liposomal doxorubicin-induced toxicity: depletion and impairment of phagocytic activity of liver macrophages. Int J Cancer 61(5):716–721.
   PubMed Web of Science ®Google Scholar
• Dai Z, Gjetting T, Mattebjerg MA, Wu C, Andresen TL. 2011. Elucidating the interplay between DNA-condensing and free polycations in gene transfection through a mechanistic study of linear and branched PEI. Biomaterials 32(33):8626–8634.
   PubMed Web of Science ®Google Scholar
• Dams ET, Oyen WJ, Boerman OC, Storm G, Laverman P, Kok PJ, et al. 2000. 99mTc-PEG liposomes for the scintigraphic detection of infection and inflammation: clinical evaluation. J Nucl Med 41(4):622–630.
   PubMedGoogle Scholar
• Dokka S, Toledo D, Shi X, Castranova V, Rojanasakul Y. 2000. Oxygen radical-mediated pulmonary toxicity induced by some cationic liposomes. Pharm Res 17(5):521–525.
   PubMed Web of Science ®Google Scholar
• Donaldson K. 2006. Resolving the nanoparticles paradox. Nanomedicine.(Lond) 1(2):229–234.
   PubMedGoogle Scholar
• Duan WR, Garner DS, Williams SD, Funckes-Shippy CL, Spath IS, Blomme EA. 2003. Comparison of immunohistochemistry for activated caspase-3 and cleaved cytokeratin 18 with the TUNEL method for quantification of apoptosis in histological sections of PC-3 subcutaneous xenografts. J Pathol 199(2):221–228.
   PubMed Web of Science ®Google Scholar
• Gao H, Shi W, Freund LB. 2005. Mechanics of receptor-mediated endocytosis. Proc Natl Acad Sci USA 102(27):9469–9474.
   PubMed Web of Science ®Google Scholar
• Gjetting T, Andresen TL, Christensen CL, Cramer F, Poulsen TT, Poulsen HS. 2011. A simple protocol for preparation of a liposomal vesicle with encapsulated plasmid DNA that mediate high accumulation and reporter gene activity in tumor tissue. Results Pharm Sci 1(1):49–56.
   PubMedGoogle Scholar
• Hu YL, Gao JQ. 2010. Potential neurotoxicity of nanoparticles. Int J Pharm 394(1-2):115–121.
   PubMed Web of Science ®Google Scholar
• Kagan VE, Bayir H, Shvedova AA. 2005. Nanomedicine and nanotoxicology: two sides of the same coin. Nanomedicine 1(4):313–316.
   PubMedGoogle Scholar
• Kreuter J, Alyautdin RN, Kharkevich DA, Ivanov AA. 1995. Passage of peptides through the blood-brain barrier with colloidal polymer particles (nanoparticles). Brain Res 674(1):171–174.
   PubMed Web of Science ®Google Scholar
• Kreuter J, Gelperina S. 2008. Use of nanoparticles for cerebral cancer. Tumori 94(2):271–277.
   PubMed Web of Science ®Google Scholar
• Kreuter J. 2001. Nanoparticulate systems for brain delivery of drugs. Adv Drug Deliv Rev 47(1):65–81.
   PubMed Web of Science ®Google Scholar
• Kuhn HG, Dickinson-Anson H, Gage FH. 1996. Neurogenesis in the dentate gyrus of the adult rat: age-related decrease of neuronal progenitor proliferation. J Neurosci 16(6):2027–2033.
   PubMed Web of Science ®Google Scholar
• Li N, Sioutas C, Cho A, Schmitz D, Misra C, Sempf J, et al. 2003. Ultrafine particulate pollutants induce oxidative stress and mitochondrial damage. Environ Health Perspect 111(4):455–460.
   PubMed Web of Science ®Google Scholar
• Linkov I, Satterstrom FK, Corey LM. 2008. Nanotoxicology and nanomedicine: making hard decisions. Nanomedicine 4(2):167–171.
   PubMed Web of Science ®Google Scholar
• Linse S, Cabaleiro-Lago C, Xue WF, Lynch I, Lindman S, Thulin E, et al. 2007. Nucleation of protein fibrillation by nanoparticles. Proc Natl Acad Sci USA 104(21):8691–8696.
   PubMedGoogle Scholar
• Lo EH, Singhal AB, Torchilin VP, Abbott NJ. 2001. Drug delivery to damaged brain. Brain Res Brain Res Rev 38(1-2):140–148.
   PubMedGoogle Scholar
• Lv H, Zhang S, Wang B, Cui S, Yan J. 2006. Toxicity of cationic lipids and cationic polymers in gene delivery. J Control Release 114(1):100–109.
   PubMed Web of Science ®Google Scholar
• Medina C, Santos-Martinez MJ, Radomski A, Corrigan OI, Radomski MW. 2007. Nanoparticles: pharmacological and toxicological significance. Br J Pharmacol 150(5):552–558.
   PubMed Web of Science ®Google Scholar
• Mignone JL, Kukekov V, Chiang AS, Steindler D, Enikolopov G. 2004. Neural stem and progenitor cells in nestin-GFP transgenic mice. J Comp Neurol 469(3):311–324.
   PubMed Web of Science ®Google Scholar
• Minchin R. 2008. Nanomedicine: sizing up targets with nanoparticles. Nat Nanotechnol 3(1):12–13.
   PubMedGoogle Scholar
• Moghimi SM, Hamad I. 2008. Liposome-mediated triggering of complement cascade. J Liposome Res 18(3):195–209.
   PubMed Web of Science ®Google Scholar
• Moghimi SM, Hunter AC. 2001. Recognition by macrophages and liver cells of opsonized phospholipid vesicles and phospholipid headgroups. Pharm Res 18(1):1–8.
   PubMed Web of Science ®Google Scholar
• Moghimi SM, Kissel T. 2006. Particulate nanomedicines. Adv Drug Deliv Rev 58(14):1451–1455.
   PubMedGoogle Scholar
• Mullen RJ, Buck CR, Smith AM. 1992. NeuN, a neuronal specific nuclear protein in vertebrates. Development 116(1):201–211.
   PubMed Web of Science ®Google Scholar
• Myer DJ, Gurkoff GG, Lee SM, Hovda DA, Sofroniew MV. 2006. Essential protective roles of reactive astrocytes in traumatic brain injury. Brain 129(Pt 10):2761–2772.
   PubMed Web of Science ®Google Scholar
• Nakanishi T, Kunisawa J, Hayashi A, Tsutsumi Y, Kubo K, Nakagawa S, et al. 1997. Positively charged liposome functions as an efficient immunoadjuvant in inducing immune responses to soluble proteins. Biochem Biophys Res Commun 240(3):793–797.
   PubMed Web of Science ®Google Scholar
• Nakanishi T, Kunisawa J, Hayashi A, Tsutsumi Y, Kubo K, Nakagawa S, et al. 1999. Positively charged liposome functions as an efficient immunoadjuvant in inducing cell-mediated immune response to soluble proteins. J Control Release 61(1-2):233–240.
   PubMed Web of Science ®Google Scholar
• Nel A, Xia T, Madler L, Li N. 2006. Toxic potential of materials at the nanolevel. Science 311(5761):622–627.
   PubMed Web of Science ®Google Scholar
• Nel AE, Madler L, Velegol D, Xia T, Hoek EM, Somasundaran P, et al. 2009. Understanding biophysicochemical interactions at the nano- bio interface. Nat Mater 8(7):543–557.
   PubMed Web of Science ®Google Scholar
• Oberdorster G, Oberdorster E, Oberdorster J. 2005. Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles. Environ Health Perspect 113(7):823–839.
   PubMed Web of Science ®Google Scholar
• Oberdorster G, Stone V, Donaldson K. 2007. Toxicology of nanoparticles: a historical perspective. Nanotoxicology 1:12–25.
   Google Scholar
• O'Callaghan JP, Jensen KF. 1992. Enhanced expression of glial fibrillary acidic protein and the cupric silver degeneration reaction can be used as sensitive and early indicators of neurotoxicity. Neurotoxicology 13(1):113–122.
   PubMed Web of Science ®Google Scholar
• O'Callaghan JP. 1991. Assessment of neurotoxicity: use of glial fibrillary acidic protein as a biomarker. Biomed Environ Sci 4(1-2):197–206.
   PubMedGoogle Scholar
• O'Callaghan JP. 1994. Biochemical analysis of glial fibrillary acidic protein as a quantitative approach to neurotoxicity assessment: advantages, disadvantages and application to the assessment of NMDA receptor antagonist-induced neurotoxicity. Psychopharmacol Bull 30(4):549–554.
   PubMedGoogle Scholar
• Ohsawa K, Imai Y, Sasaki Y, Kohsaka S. 2004. Microglia/macrophage-specific protein Iba1 binds to fimbrin and enhances its actin-bundling activity. J Neurochem 88(4):844–856.
   PubMed Web of Science ®Google Scholar
• Owens DE 3rd, Peppas NA. 2006. Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles. Int J Pharm 307(1):93–102.
   PubMed Web of Science ®Google Scholar
• Park JH, Lee S, Kim JH, Park K, Kim K, Kwon IC. 2008. Polymeric nanomedicine for cancer therapy. Prog Polym Sci 33(1):113–137.
   Web of Science ®Google Scholar
• Paxinos G, Watson C. 2008. The rat brain in stereotaxic coordinates. 6th ed. pp 1–400.
   Google Scholar
• Peers PV, Cusack R, Duncan J. 2006. Modulation of spatial bias in the dual task paradigm: evidence from patients with unilateral parietal lesions and controls. Neuropsychologia 44(8):1325–1335.
   PubMed Web of Science ®Google Scholar
• Rochefort C, Arabo A, Andre M, Poucet B, Save E, Rondi-Reig L. 2011. Cerebellum shapes hippocampal spatial code. Science 334(6054):385–389.
   PubMed Web of Science ®Google Scholar
• Roney C, Kulkarni P, Arora V, Antich P, Bonte F, Wu A, et al. 2005. Targeted nanoparticles for drug delivery through the blood-brain barrier for Alzheimer's disease. J Control Release 108(2-3):193–214.
   PubMedGoogle Scholar
• Sapra P, Allen TM. 2003. Ligand-targeted liposomal anticancer drugs. Prog Lipid Res 42(5):439–462.
   PubMed Web of Science ®Google Scholar
• Scheule RK, St George JA, Bagley RG, Marshall J, Kaplan JM, Akita GY, et al. 1997. Basis of pulmonary toxicity associated with cationic lipid-mediated gene transfer to the mammalian lung. Hum Gene Ther 8(6):689–707.
   PubMed Web of Science ®Google Scholar
• Schmued LC, Hopkins KJ. 2000a. Fluoro-Jade B: a high affinity fluorescent marker for the localization of neuronal degeneration. Brain Res 874(2):123–130.
   PubMed Web of Science ®Google Scholar
• Schmued LC, Hopkins KJ. 2000b. Fluoro-Jade: novel fluorochromes for detecting toxicant-induced neuronal degeneration. Toxicol Pathol 28(1):91–99.
   PubMed Web of Science ®Google Scholar
• Sharma HS, Sharma A. 2007. Nanoparticles aggravate heat stress induced cognitive deficits, blood-brain barrier disruption, edema formation and brain pathology. Prog Brain Res 162:245–273.
   PubMed Web of Science ®Google Scholar
• Shvedova AA, Kisin ER, Porter D, Schulte P, Kagan VE, Fadeel B, et al. 2009. Mechanisms of pulmonary toxicity and medical applications of carbon nanotubes: Two faces of Janus? Pharmacol Ther 121(2):192–204.
   PubMed Web of Science ®Google Scholar
• Soenen SJ, Brisson AR, De Cuyper M. 2009. Addressing the problem of cationic lipid-mediated toxicity: the magnetoliposome model. Biomaterials 30(22):3691–3701.
   PubMedGoogle Scholar
• Szebeni J, Bedocs P, Rozsnyay Z, Weiszhár Z, Urbanics R, Rosivall L, et al. 2011. Liposome-induced complement activation and related cardiopulmonary distress in pigs: factors promoting reactogenicity of doxil and ambisome. Nanomedicine 8(2):176–184.
   PubMedGoogle Scholar
• Szebeni J, Moghimi SM. 2009. Liposome triggering of innate immune responses: a perspective on benefits and adverse reactions. J Liposome Res 19(2):85–90.
   PubMed Web of Science ®Google Scholar
• Szebeni J. 2005. Complement activation-related pseudoallergy: a new class of drug-induced acute immune toxicity. Toxicology 216(2-3):106–121.
   PubMed Web of Science ®Google Scholar
• Thomas M, Klibanov AM. 2003. Non-viral gene therapy: polycation- mediated DNA delivery. Appl Microbiol Biotechnol 62(1):27–34.
   PubMed Web of Science ®Google Scholar
• Vega-Villa KR, Takemoto JK, Yanez JA, Remsberg CM, Forrest ML, Davies NM. 2008. Clinical toxicities of nanocarrier systems. Adv Drug Deliv Rev 60(8):929–938.
   PubMed Web of Science ®Google Scholar
• Zhang YF, Boado RJ, Pardridge WM. 2003. Absence of toxicity of chronic weekly intravenous gene therapy with pegylated immunoliposomes. Pharm Res 20(11):1779–1785.
   PubMed Web of Science ®Google Scholar